Dyax/Bayer Schering Ink Antibody Discovery Agreement
This article was originally published in The Pink Sheet Daily
Executive Summary
External licensing and discovery agreements support internal pipeline growth, goal of total integration, Dyax CEO tells “The Pink Sheet” DAILY.